New patent for Teva Branded drug PROAIR DIGIHALER

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for PROAIR+DIGIHALER
Annual Drug Patent Expirations for PROAIR+DIGIHALER

Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are eighteen patents protecting this drug.

Drug patent litigation for PROAIR DIGIHALER.

This drug has two hundred and ninety-nine patent family members in thirty-one countries.

The generic ingredient in PROAIR DIGIHALER is albuterol sulfate. Two suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top